Research

2020年

  1. Kadoya H, Satoh M, Nishi Y, Kondo M, Wada Y, Sogawa Y, Kidokoro K, Nagasu H, Sasaki T, Kashihara N　： Klotho is a novel therapeutic target in peritoneal fibrosis via Wnt signaling inhibition.  Nephrology Dialysis Transplantation. 1-9,2020

2019年

  1. Kidokoro K, Cherney D, Bozovic A, Nagasu H, Satoh M, Kanda E, Sasaki T, Kashihara N： Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging.　Circulation. 22(2) : 140(4):303 – 315, 2019
  2. Nagasu H, Sogawa Y, Kidokoro K, Itano S, Yamamoto T, Satoh M, Sasaki T, Suzuki T, Yamamoto M, Wigley W Christian, Proksch Joel W, Meyer Colin J, Kashihara N： Bardoxolone methyl analog attenuates proteinuria induced tubular damage by modulating mitochondrial function.　FASEB J. 33(11) : 12253 – 12263, 2019
  3. Kashihara N, Kidokoro K, Kanda E： Renoprotective effects of sodium-glucose cotransporter-2 inhibitors and underlying mechanisms．Current Opinion in Nephrology and Hypertension. 29(1) : 112 – 118, 2019
  4. Kashihara N, Kohsaka S, Kanda E, Okami S, Yajima T： Hyperkalemia in Real-World Patients Under Continuous Medical Care in Japan．　Kidney International Reports. 4(9) : 1248 – 1260, 2019
  5. Fukui A, Yokoo T, Nangaku M, Kashihara N： New measures against chronic kidney diseases in Japan since 2018.  Clinical and Experimental Nephrology 23(11) : 1263 – 1271, 2019
  6. Tang SCW, Yu X, Chen HC, Kashihara N, Park HC, Liew A, Goh BL, Nazareth MGC, Bunnag S, Tan J, Lun V, Lydia A, Sharma SK, Hoque E, Togtokh A, Ghnaimet M, Jha V： Dialysis Care and Dialysis Funding in Asia．American journal of kidney diseases  ISSN : 1523 – 6838, 2019
  7. Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, Horio T, Hoshide S, Ikeda S, Ishimitsu T, Ito M, Ito S, Iwashima Y, Kai H, Kamide K, Kanno Y, Kashihara N, Kawano Y, Kikuchi T, Kitamura K, Kitazono T, Kohara K, Kudo M, Kumagai H, Matsumura K, Matsuura H, Miura K, Mukoyama M, Nakamura S, Ohkubo T, Ohya Y, Okura T, Rakugi H, Saitoh S, Shibata H, Shimosawa T, Suzuki H, Takahashi S, Tamura K, Tomiyama H, Tsuchihashi T, Ueda S, Uehara Y, Urata H, Hirawa N： The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)．　Hypertens Res. 42(9) : 1235 – 1481, 2019
  8. Nakamura S, Hasebe N, Yatabe M, Kishi T, Ishida M, Ichihara A, Node K, Ishimitsu T, Itoh H, Ito M, Ohishi M, Ohkubo T, Kai H, Kashihara N, Kario K, Saitoh S, Tsuchihashi T, Nishiyama A, Higaki J, Miura K, Rakugi H, Kawano Y, Tamura K, Yatabe T, Ohya Y, Ito S： JSH Statement: Asahikawa declaration in promotion of diversity by the Japanese society of hypertension-the JSH Asahikawa declaration.　Hypertens Res. 42(10) : 1483 – 1484, 2019
  9. Japanese Society of Nephrology (Kashihara N.)： Essential points from Evidence-based Clinical Practice Guidelines for Chronic Kidney Disease 2018.　Clin Exp Nephrol. 23(1) : 1 – 15, 2019
  10. Kidokoro K, Cherney D, Bozovic A, Nagasu H, Satoh M, Sasaki T, Kashihara N： EVALUATION OF THE DIABETIC GLOMERULAR HEMODYNAMICS BY SGLT2 INHIBITOR EMPAGLIFLOZIN USING IN VIVO IMAGING.　Kidney International Reports Vol.4(7) : 132 – 132, 2019
  11. Nagasu A, Mukai T, Iseki M, Kawahara K, Tsuji S, Nagasu H, Ueki Y, Ishihara K, Kashihara N, Morita Y： Sh3bp2 Gain-Of-Function Mutation Ameliorates Lupus Phenotypes in B6.MRL-Faslpr Mice.　Cells. 8(5) : 402, 2019
  12. Uchida A, Kidokoro K, Sogawa Y, Itano S, Nagasu H, Satoh M, Sasaki T, Kashihara N： 5-Aminolevulinic acid exerts renoprotective effect via Nrf2 activation in murine rhabdomyolysis-induced acute kidney injury．　Cells. Vol.8(5) : 402, 2019
  13. Satoh M, Maruhashi T, Yoshida Y, Shibata H： Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronis．　Hypertension Research. 42 : 817 – 824, 2019
  14. Masaaki Ito, Toshihiko Ishimitsu, Atsuhiro Ichihara, Hiroshi Itoh, Mitsuru Ohishi, Takayoshi Ohkubo, Hisashi Kai, Naoki Kashihara, Kazuomi Kario, Shigeyuki Saitoh, Takuya Tsuchihashi, Satoko Nakamura, Akira Nishiyama, Koichi Node, Naoyuki Hasebe, Jitsuo Higaki, Katsuyuki Miura, Hiromi Rakugi, Kouichi Tamura, Yuhei Kawano, Takashi Yatabe, Yusuke Ohya & Sadayoshi Ito：
    JSH Statement: Kyoto declaration on hypertension research in Asia.　Hypertension Res. 42(6) : 759 – 760, 2019

2018年

  1. Hoshino J, Nagai K, Kai H, Saito C, Ito Y, Asahi K, Kondo M, Iseki K, Iseki C, Okada H, Kashihara N, Narita I, Wada T, Combe C, Pisoni RL, Robinson BM, Yamagata K: A nationwide prospective cohort study of patients with advanced chronic kidney disease in Japan .　The Reach-J CKD cohort study. Clin Exp Nephrol. 22(2):309-317, 2018
  2. Kanda E, Usui T, Kashihara N, Iseki C, Iseki K, Nangaku M: Importance of glomerular filtration rate change as surrogate endpoint for the future incidence of end-stage renal disease in general Japanese population: community-based cohort study. 　Clin Exp Nephrol. 22(2):318-327, 2018
  3. Porter RS, Murata-Nakamura Y, Nagasu H, Kim HG, Iwase S: Transcriptome Analysis Revealed Impaired cAMP Responsiveness in PHF21A-Deficient Human Cells. Neuroscience. 370(2):170-180, 2018
  4. Komatsu H, Fujimoto S, Maruyama S, Mukoyama M, Sugiyama H, Tsuruya K, Satoh H, Soma J, Yano J, Itano S, Nishino T, Sato T, Narita I, Yokoyama H: Distinict characteristics and outcomes in elderly-onset IgA vasculitis(Henoch-Schönlein purpura) with nephritis: Nationwide cohort study of data from the Japan Renal Biopsy Registry (J-RBR). 　PLoS One. 13(5):e0196955, 2018
  5. Doi K, Nishida O, Shigematsu T, Sadahiro T, Itami N, Iseki K, Yuzawa Y, Okada H, Koya D, Kiyomoto H, Shibagaki Y, Matsuda K, Kato A, Hayashi T, Ogawa T, Tsukamoto T, Noiri E, Negi S, Kamei K, Kitayama H, Kashihara N, Moriyama T, Terada Y: Japanese Clinical Practice Guideline for Acute Kidney Injury 2016 Committee.  The Japanese clinical practice guideline for acute kidney injury 2016. Clin Exp Nephrol. 22(5):985-1045, 2018
  6. Kanda E, Kashihara N, Matsushita K, Usui T, Okada H, Iseki K, Mikami K, Tanaka T, Wada T, Watada H, Ueki K, Nangaku M: Research Working Group for Establishing Guidelines for Clinical Evaluation of Chronic Kidney Disease. Guidelines for clinical evaluation of chronic kidney disease : AMED research on regulatory science of pharmaceuticals and medical devices. Clin Exp Nephrol. 22(6):1446-1475, 2018
  7. Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Yoshio T, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y: Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study. 　Clin Exp Nephrol. 22(6):1266-1280, 2018
  8. Usui T, Kanda E, Iseki C, Iseki K, Kashihara N, Nangaku M.: Observation period for changes in proteinuria and risk prediction of end-stage renal disease in general population. 　Nephrology (Carlton). 23(9):821-829, 2018
  9. Sogawa Y, Nagasu H, Itano S, Kidokoro K, Taniguchi S, Takahashi M, Kadoya H, Satoh M, Sasaki T, Kashihara N: The eNOS-NO pathway attenuates kidney dysfunction via suppression of inflammasome activation in aldosterone-induced renal injury model mice. 　PLoS One. 13(10):e0203823, 2018
  10. Node K, Kishi T, Tanaka A, Itoh H, Rakugi H, Ohya Y, Miura K, Okamura T, Ishimitsu T, Ichihara A, Ito M, Ohishi M, Ohkubo T, Kai H, Kashihara N, Kario K, Saitoh S, Tsuchihashi T, Nakamura S, Nishiyama A, Hasebe N, Higaki J, Tamura K, Kawano Y, Yatabe T, Ito S: JSH Future Plan Working Group and Executive Board Members. The Japanese Society of Hypertension-Digest of plan for the future. 　Hypertens Res. 41(12):989-990, 2018